KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis

Nephrology Dialysis Transplantation

Volumn 29, Issue 2, 2014, Pages 313-324

  Huang, Chunling ^a,b   Shen, Sylvie ^a   Ma, Qing ^a   Gill, Anthony ^a   Pollock, Carol A ^a   Chen, Xin Ming ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b XIAMEN UNIVERSITY   (China)

Author keywords

diabetic nephropathy; fibroblast activation; KCa3.1; renal interstitial fibrosis

Indexed keywords

1 [(2 CHLOROPHENYL)DIPHENYLMETHYL] 1H PYRAZOLE; ALPHA SMOOTH MUSCLE ACTIN; CALVASCULIN; COLLAGEN TYPE 1; FIBRONECTIN; GELATINASE A; GELATINASE B; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; RNA; SMAD2 PROTEIN; SMAD3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; DIABETES MELLITUS; EXPERIMENTAL DIABETES MELLITUS; FIBROBLAST; FIBROGENESIS; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY FIBROSIS; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA ISOLATION; WILD TYPE;

DIABETIC NEPHROPATHY; FIBROBLAST ACTIVATION; KCA3.1; RENAL INTERSTITIAL FIBROSIS;

ANIMALS; BIOPSY; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; FIBROBLASTS; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; KIDNEY CORTEX; MALE; MICE; MICE, INBRED C57BL; PYRAZOLES; REAL-TIME POLYMERASE CHAIN REACTION; RNA; SIGNAL TRANSDUCTION;

EID: 84896700915     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft431     Document Type: Article

References (45)

1. Zeisberg M, Neilson EG.Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 2010; 21: 1819-1834
2. Desmouliere A, Darby IA, Gabbiani G. Normal and pathologic soft tissue remodeling: Role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab Invest 2003; 83: 1689-1707
3. Lan HY. Diverse roles of TGF-beta/Smads in renal fibrosis and inflammation. Int J Biol Sci 2011; 7: 1056-1067
4. Wolf G. Growth factors and the development of diabetic nephropathy. Curr Diab Rep 2003; 3: 485-490
5. Prud'homme GJ. Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab Invest 2007; 87: 1077-1091
6. Krag S, Danielsen CC, Carmeliet P et al. Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-beta1-induced kidney disease. Kidney Int 2005; 68: 2651-2666
7. Hwang M, Kim HJ, Noh HJ et al. TGF-beta1 siRNA suppresses the tubulointerstitial fibrosis in the kidney of ureteral obstruction. Exp Mol Pathol 2006; 81: 48-54
8. Chou CC, Lunn CA, Murgolo NJ. KCa3.1: Target and marker for cancer, autoimmune disorder and vascular inflammation?. Expert Rev Mol Diagn 2008; 8: 179-187
9. Hu L, Pennington M, Jiang Q et al. Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes. J Immunol 2007; 179: 4563-4570
10. Tao R, Lau CP, Tse HF et al. Regulation of cell proliferation by intermediate-conductance Ca2+-Activated potassium and volume-sensitive chloride channels in mouse mesenchymal stem cells. Am J Physiol Cell Physiol 2008; 295: C1409-C1416
11. Tharp DL, Bowles DK. The intermediate-conductance Ca2+-Activated K+ channel (KCa3.1) in vascular disease. Cardiovasc Hematol Agents Med Chem 2009; 7: 1-11
12. Toyama K, Wulff H, Chandy KG et al. The intermediate-conductance calcium-Activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans. J Clin Invest 2008; 118: 3025-3037
13. Kohler R, Wulff H, Eichler I et al. Blockade of the intermediate- conductance calcium-Activated potassium channel as a new therapeutic strategy for restenosis. Circulation 2003; 108: 1119-1125
14. Wulff H, Kolski-Andreaco A, Sankaranarayanan A et al. Modulators of small-And intermediate-conductance calcium-Activated potassium channels and their therapeutic indications. Curr Med Chem 2007; 14: 1437-1457
15. Ohya S, Kimura K, Niwa S et al. Malignancy grade-dependent expression of K+-channel subtypes in human prostate cancer. J Pharmacol Sci 2009; 109: 148-151
16. Huang C, Shen S, Ma Q et al. Blockade of KCa3.1 ameliorates renal fibrosis through a TGF-b1/Smad pathway in diabetic mice. Diabetes 2013; 62: 2923-2934
17. Johnson DW, Saunders HJ, Brew BK et al. Human renal fibroblasts modulate proximal tubule cell growth and transport via the IGF-I axis. Kidney Int 1997; 52: 1486-1496
18. Wulff H, Gutman GA, Cahalan MD et al. Delineation of the clotrimazole/ TRAM-34 binding site on the intermediate conductance calcium-Activated potassium channel, IKCa1. J Biol Chem 2001; 276: 32040-32045
19. Wulff H, Miller MJ, Hansel W et al. Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-Activated K+ channel, IKCa1: A potential immunosuppressant. Proc Natl Acad Sci USA 2000; 97: 8151-8156
20. Brosius FC, III, Alpers CE, Bottinger EP et al. Mouse models of diabetic nephropathy. J Am Soc Nephrol 2009; 20: 2503-2512
21. Tesch GH, Allen TJ. Rodent models of streptozotocin-induced diabetic nephropathy. Nephrology (Carlton) 2007; 12: 261-266
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-Time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods 2001; 25: 402-408
23. Doi S, Zou Y, Togao O et al. Klotho inhibits transforming growth factorbeta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem 2011; 286: 8655-8665
24. Ghosh AK, Vaughan DE. PAI-1 in tissue fibrosis. J Cell Physiol 2012; 227: 493-507
25. Hewitson TD. Renal tubulointerstitial fibrosis: Common but never simple. Am J Physiol Renal Physiol 2009; 296: F1239-F1244
26. Iwano M, Plieth D, Danoff TM et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110: 341-350
27. Huang Y, Noble NA. PAI-1 as a target in kidney disease. Curr Drug Targets 2007; 8: 1007-1015
28. Eddy AA, Fogo AB. Plasminogen activator inhibitor-1 in chronic kidney disease: Evidence and mechanisms of action. J Am Soc Nephrol 2006; 17: 2999-3012
29. Catania JM, Chen G, Parrish AR. Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol 2007; 292: F905-F911
30. Heeg MH, Koziolek MJ, Vasko R et al. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway. Kidney Int 2005; 68: 96-109
31. Yamashita S, Maeshima A, Nojima Y. Involvement of renal progenitor tubular cells in epithelial-To-mesenchymal transition in fibrotic rat kidneys. J Am Soc Nephrol 2005; 16: 2044-2051
32. Li J, Qu X, Bertram JF. Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am J Pathol 2009; 175: 1380-1388
33. Li J, Deane JA, Campanale NV et al. The contribution of bone marrowderived cells to the development of renal interstitial fibrosis. Stem Cells 2007; 25: 697-706
34. Lin SL, Kisseleva T, Brenner DA et al. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 2008; 173: 1617-1627
35. Lebleu VS, Taduri G, O'Connell J et al. Origin and function of myofibroblasts in kidney fibrosis. Nat Med 2013; 19: 1047-1053
36. Liu Y. Renal fibrosis: New insights into the pathogenesis and therapeutics. Kidney Int 2006; 69: 213-217
37. Grgic I, Kiss E, Kaistha BP et al. Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels. Proc Natl Acad Sci USA 2009; 106: 14518-14523
38. Ouadid-Ahidouch H, Roudbaraki M, Delcourt P et al. Functional and molecular identification of intermediate-conductance Ca(2+)-Activated K(+) channels in breast cancer cells: Association with cell cycle progression. Am J Physiol Cell Physiol 2004; 287: C125-C134
39. Jager H, Dreker T, Buck A et al. Blockage of intermediate-conductance Ca2+-Activated K+ channels inhibit human pancreatic cancer cell growth in vitro. Mol Pharmacol 2004; 65: 630-638
40. Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 2007; 127: 526-537
41. Rodriguez-Pena AB, Grande MT, Eleno N et al. Activation of Erk1/2 and Akt following unilateral ureteral obstruction. Kidney Int 2008; 74: 196-209
42. Mankhey RW, Bhatti F, Maric C. 17beta-Estradiol Replacement improves renal function and pathology associated with diabetic nephropathy. Am J Physiol Renal Physiol 2005; 288: F399-F405
43. Cheng S, Lovett DH. Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation. Am J Pathol 2003; 162: 1937-1949
44. Tan TK, Zheng G, Hsu TT et al. Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells. Am J Pathol 2010; 176: 1256-1270
45. Kalluri R. EMT: When epithelial cells decide to become mesenchymal-like cells. J Clin Invest 2009; 119: 1417-1419